{
    "Trade/Device Name(s)": [
        "BioSieve\u2122 Fentanyl FIA Test Kit",
        "BioSieve\u2122 ToxiSmart FIA Reader"
    ],
    "Submitter Information": "VivaChek Biotech (Hangzhou) Co., Ltd.",
    "510(k) Number": "K240124",
    "Predicate Device Reference 510(k) Number(s)": [
        "K220046"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "KHO"
    ],
    "Summary Letter Date": "June 14, 2024",
    "Summary Letter Received Date": "May 10, 2024",
    "Submission Date": "June 12, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.2560"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Fluorometer for clinical use"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Fentanyl"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BioSieve\u2122 ToxiSmart FIA Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence immunoassay (FIA)",
        "Lateral flow immunochromatography"
    ],
    "Methodologies": [
        "Competitive binding immunochemistry",
        "Immunochromatographic assay"
    ],
    "Submission Type(s)": [
        "Test Kit",
        "Analyzer",
        "Reader"
    ],
    "Document Summary": "FDA 510(k) summary for BioSieve\u2122 Fentanyl FIA Test Kit and BioSieve\u2122 ToxiSmart FIA Reader for qualitative fentanyl determination in urine by fluorescence immunoassay",
    "Indications for Use Summary": "Qualitative determination of fentanyl in human urine at 1.0 ng/mL cutoff using BioSieve\u2122 Fentanyl FIA Test Kit and BioSieve\u2122 ToxiSmart FIA Reader; provides preliminary results for in vitro diagnostic and prescription use",
    "fda_folder": "Toxicology"
}